hims novo nordisk - Search News

News

Hims & Hers stock price soars

The Boston Globe · 1d

Novo Nordisk teams with telehealth firms Hims, Ro to sell Wegovy at lower price

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own obesity medication,

Fox Business on MSN · 2d

Hims & Hers partners with Novo Nordisk to sell Wegovy

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.

Fast Company on MSN · 2d

Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy

The deal will allow the telehealth company to offer the Danish drugmaker’s popular GLP-1 drug on its platform. Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo Nordisk.

11hon MSN

Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

7h

Hims & Hers: Revolutionizing Healthcare

Hims & Hers is an increasingly profitable, vertically integrated telehealth platform with major tailwinds, positioning it as ...

1d

Up 30% In A Week, HIMS Stock Is Just Getting Warmed Up

Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results